Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michael Joseph Anthony DiStefano

TitleAssistant Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-DOCP General Operations

    Collapse Research 
    Collapse research activities and funding
    R03HS029960     (DISTEFANO, MICHAEL J)Sep 1, 2024 - Aug 31, 2025
    NIH
    Measuring the Impact of Price Ceiling Controls: A Case Study of Insulin Out-of-Pocket Caps
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zemplenyi A, Leonard J, Wright GC, DiStefano MJ, Nair K, Anderson KE, McQueen RB. Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access Model. Pharmacoeconomics. 2025 May; 43(5):583-594. PMID: 39982606.
      View in: PubMed
    2. DiStefano MJ, Dardouri M, Moore GD, Saseen JJ, Nair KV. Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado. J Pharm Policy Pract. 2025; 18(1):2441220. PMID: 39776466.
      View in: PubMed
    3. DiStefano MJ, McQueen RB, Gao V, Klein MP, Snell-Bergeon JK, Polsky S. The Cost of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes Pregnancies in the United States: A Cost-Consequences Analysis Using Real-World Evidence. Diabetes Technol Ther. 2025 Apr; 27(4):329-333. PMID: 39699652.
      View in: PubMed
    4. Anderson KE, Sahu M, DiStefano MJ, Asche CV, Mattingly TJ. Pharmacy Closures and Anticonvulsant Medication Prescription Fills. JAMA. 2024 Dec 03; 332(21):1847-1849. PMID: 39495537.
      View in: PubMed
    5. Nikitin D, Mustafa RA, McQueen B, Zemplenyi A, DiStefano MJ, Nhan E, Kayali Y, Richardson M, Rind DM, Pearson SD, Agboola F. The effectiveness and value of midomafetamine-assisted psychotherapy for posttraumatic stress disorder. J Manag Care Spec Pharm. 2024 Oct; 30(10):1191-1195. PMID: 39321122.
      View in: PubMed
    6. Markell J, Odouard I, Anderson GF, DiStefano MJ. Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs. JAMA Netw Open. 2024 08 01; 7(8):e2431110. PMID: 39212994.
      View in: PubMed
    7. DiStefano MJ, Pearson SD, Rind DM, Zemplenyi A. How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative Study. Value Health. 2024 08; 27(8):1066-1072. PMID: 38679288.
      View in: PubMed
    8. DiStefano MJ, Zemplenyi A, Anderson KE, Mendola ND, Nair KV, McQueen RB. Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program. Expert Rev Pharmacoecon Outcomes Res. 2024 Feb; 24(2):171-180. PMID: 37961908.
      View in: PubMed
    9. DiStefano MJ, Zemplenyi A, McQueen RB. Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement. J Manag Care Spec Pharm. 2024 Mar 01; 30(3):252-258. PMID: 38241282.
      View in: PubMed
    10. Zemplenyi A, Leonard J, DiStefano MJ, Anderson KE, Wright GC, Mendola ND, Nair K, McQueen RB. Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid. Pharmacoeconomics. 2024 Mar; 42(3):319-328. PMID: 37989969.
      View in: PubMed
    11. DiStefano MJ, Levy JF, Odouard IC, Anderson GF. Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations. Value Health. 2023 11; 26(11):1618-1624. PMID: 37689264.
      View in: PubMed
    12. Anderson KE, DiStefano MJ, Liu A, Mattingly TJ, Socal MP, Anderson GF. Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs. Value Health. 2023 09; 26(9):1381-1388. PMID: 37285915.
      View in: PubMed
    13. DiStefano MJ, Karim SA, Krubiner CB, Hofman KJ. Integrating Health Technology Assessment and the Right to Health in South Africa: A Qualitative Content Analysis of Substantive Values in Landmark Judicial Decisions. J Law Med Ethics. 2023; 51(1):131-149. PMID: 37226744.
      View in: PubMed
    14. DiStefano MJ, Kang SY, Parasrampuria S, Anderson GF. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance. JAMA Health Forum. 2023 05 05; 4(5):e231090. PMID: 37234016.
      View in: PubMed
    15. DiStefano MJ, Markell JM, Doherty CC, Alexander GC, Anderson GF. Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising. JAMA. 2023 02 07; 329(5):386-392. PMID: 36749334.
      View in: PubMed
    16. DiStefano MJ, Alexander GC, Anderson GF. Reply to: The informed majority could help make research into Alzheimer's disease fairer and more efficient. J Am Geriatr Soc. 2022 06; 70(6):1883-1885. PMID: 35343584.
      View in: PubMed
    17. DiStefano MJ, Alexander GC, Polsky D, Anderson GF. Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey. J Am Geriatr Soc. 2022 06; 70(6):1685-1694. PMID: 35129210.
      View in: PubMed
    18. DiStefano MJ, Kang SY, Yehia F, Morales C, Anderson GF. Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs. Value Health. 2021 03; 24(3):397-403. PMID: 33641774.
      View in: PubMed
    19. Kang SY, Bai G, DiStefano MJ, Socal MP, Yehia F, Anderson GF. Comparative Approaches to Drug Pricing. Annu Rev Public Health. 2020 04 02; 41:499-512. PMID: 31874070.
      View in: PubMed
    20. Kang SY, DiStefano MJ, Socal MP, Anderson GF. Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries. Health Aff (Millwood). 2019 05; 38(5):804-811. PMID: 31059372.
      View in: PubMed
    DiStefano's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (69) concept(s)
    _
    Co-Authors Expand Description
    See all (6) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)